Five Questions with KKR’s Jim Momtazee


KKR, Kohlberg Kravis Roberts, healthcare, private equity
  • PE giant opportunistic when it comes to sectors
  • Relationship-building a key deal-sourcing element
  • August buys: Envision unit, Covenant, PharMerica
Jim Momtazee leads the healthcare investment team at KKR, one of the most active buyers in the sector in recent weeks. How has KKR’s healthcare investing strategy evolved over the past five years? The biggest change for us would be ...

This content is available for Buyouts subscribers only. Request a free trial to get access for a limited period

If you already have an active Buyouts subscription, please sign in to view this article.

Digital Edition

BO_092517_cover

To read a digital copy of our latest magazine

click here

PE News Briefs